Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06822725 · ClinicalTrials.gov registry record
The Sinonasal Microbiome
A clinical trial of Chronic Rhinosinusitis (Diagnosis) and Sinonasal Disorder, sponsored by University of Chicago.
- Active
- Registry status
- 285
- Enrollment target
- 1
- Study location
NCT06822725 is a study of Chronic Rhinosinusitis (Diagnosis) and Sinonasal Disorder that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 285 participants, above the 59-participant average among 9 other Chronic Rhinosinusitis (Diagnosis) trials with a reported enrollment target (383% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06822725, a study of Chronic Rhinosinusitis (Diagnosis) and Sinonasal Disorder, is active but no longer recruiting, sponsored by University of Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- 285 participants
- Enrollment target
- 1
- Study location
Study Summary
Chronic rhinosinusitis is an inflammatory disease of the sinonasal mucosa with significant impact and limited treatment options. Chronic rhinosinusitis (CRS) poses an important public health problem and causes a large impact on individual quality of life. Studies of CRS have been limited by access to tissue, the complexity of the sinonasal physiology, a lack of available biomarkers, the absence of useful animal models, a paucity of cohorts with biological samples for analysis, and limited well-designed clinical trials or investigations of immune function. Therefore, novel strategies for identifying biological mechanisms underlying this disease are in great need. Using prospective samples from well characterized subjects, the investigators intend to profile the mucosa associated-bacteria in the nose and sinuses. In parallel, using sinus tissue from patients undergoing surgery, the site will interrogate the epithelium for mucosal immune function to understand host-microbe interaction. This study hypothesizes that the microbial profile of the sinuses initiates an immune responses which leads to chronic inflammation in susceptible people. This study would provide the first comprehensive data on what bacteria are present in the nose and sinus and could lead to important knowledge useful in sinonasal disease.
Conditions Studied
Interventions
- OTHER Control Group
- PROCEDURE Chronic rhinosinusitis (CRS) with and without Nasal Polyposis
Study Locations (1)
Illinois
- The University of Chicago - Hyde Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 285 participants |
| Start Date | 2025-01-13 |
| Est. Completion | 2029-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06822725
The ClinicalTrials.gov registry entry for NCT06822725 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 285 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 59-participant average among 9 other Chronic Rhinosinusitis (Diagnosis) trials with a reported enrollment target (383% higher). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Rhinosinusitis (Diagnosis) appearing as the primary indexed condition, and to 2 interventions - of which Control Group is the first listed.
NCT06822725 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06822725 about?
NCT06822725 is a clinical study titled "The Sinonasal Microbiome". Chronic rhinosinusitis is an inflammatory disease of the sinonasal mucosa with significant impact and limited treatment options. Chronic rhinosinusitis (CRS) poses an important public health problem and causes a large impact on individual quality of life. Studies of CRS have been limited by access t...
What is the current status of trial NCT06822725?
This trial is currently active not recruiting. The enrollment target is 285 participants. The study started on 2025-01-13. Estimated completion is 2029-01.
What conditions does trial NCT06822725 study?
This clinical trial studies the following conditions: Chronic Rhinosinusitis (Diagnosis), Sinonasal Disorder.
What interventions are being tested in trial NCT06822725?
The interventions under investigation include: Control Group (OTHER), Chronic rhinosinusitis (CRS) with and without Nasal Polyposis (PROCEDURE).
Who is sponsoring clinical trial NCT06822725?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06822725 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Rhinosinusitis (Diagnosis)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis
RECRUITING · Early Phase 1
-
The Role of IL5 in Epithelial Cell Integrity
RECRUITING · Early Phase 1
-
Sinus Disease in Young Children With Cystic Fibrosis
RECRUITING
-
Topical Probiotic Sinus Irrigations for Treating Chronic Sinusitis
RECRUITING · Phase 2
-
Impact of Sinus Surgery on Individuals With Cystic Fibrosis
RECRUITING
-
Functional Endoscopic Sinus Surgery Study
ACTIVE NOT RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.